98%
921
2 minutes
20
: Cognitive impairment in spinocerebellar ataxia patients has been reported since the early-disease stage. We aimed to assess cognitive differences in SCA1 and SCA2 patients. : We performed neuropsychological (NPS) and neurophysiological (auditory event-related potentials, aERPs) assessments in 16 SCA1 and 18 SCA2 consecutive patients. Furthermore, clinical information (age at onset, disease duration, motor disability) was collected. : NPS tests yielded scores in the normal range in both groups but with lower scores in the Frontal Assessment Battery ( < 0.05) and Visual Analogue Test for Anosognosia for motor impairment ( < 0.05) in SCA1, and the Trail Making Test ( < 0.01), Raven's progressive matrices ( < 0.01), Stroop ( < 0.05), and emotion attribution tests ( < 0.05) in SCA2. aERPs showed lower N100 amplitude ( < 0.01) and prolonged N200 latency ( < 0.01) in SCA1 compared with SCA2. Clinically, SCA2 had more severe motor disability than SCA1 in the Assessment and Rating of Ataxia Scale. : SCA2 showed more significant difficulties in attentional, visuospatial, and emotional function, and greater motor impairment. In contrast, SCA1 showed less cognitive flexibility/phasic ability, probably affected by a more severe degree of dysarthria. The same group revealed less neural activity during nonconscious attentional processing (N100-N200 data), suggesting greater involvement of sensory pathways in discriminating auditory stimuli. NFS did not correlate with NPS findings, implying an independent relationship. However, the specific role of the cerebellum and cerebellar symptoms in NPS test results deserves more focus.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11355496 | PMC |
http://dx.doi.org/10.3390/jcm13164880 | DOI Listing |
Cerebellum
September 2025
Department of Neurology, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
Spinocerebellar ataxia type 27B (SCA27B), caused by GAA repeat expansions in FGF14, is an increasingly recognized form of late-onset cerebellar ataxia. However, early diagnosis remains challenging due to mild or absent cerebellar motor signs and often normal brain magnetic resonance imaging (MRI). Oculovestibular abnormalities, although prevalent, are frequently overlooked and not captured by standard clinical scales such as the Scale for the Assessment and Rating of Ataxia (SARA).
View Article and Find Full Text PDFNeurology
September 2025
Sorbonne Université, Institut du Cerveau - Paris Brain Institute-ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, France.
Background And Objectives: Cerebellar cognitive-affective syndrome (CCAS) results from cerebellar degeneration, but its prevalence in spinocerebellar ataxias (SCAs) remains underexplored. This study assessed CCAS prevalence, severity, and progression across different SCAs.
Methods: We included polyglutamine (PolyQ) SCA expansion carriers (/SCA1, /SCA2, /SCA3, and /SCA7), patients with /SCA27B and SPG7, and controls.
Marine hydrocarbon seeps are hotspots for sulphate reduction coupled to hydrocarbon oxidation. In situ metabolic rates of sulphate-reducing bacteria (SRB) degrading hydrocarbons other than methane, however, remain poorly understood. Here, we assessed the environmental role of Desulfosarcinaceae clades SCA1, SCA2 for degradation of n-butane and clade LCA2 for n-dodecane.
View Article and Find Full Text PDFMov Disord Clin Pract
July 2025
Neurological Diseases Group, Postgraduate Program in Internal Medicine, Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Background: Although traditionally recognized for motor impairment, evidence suggests that cognitive deficits may emerge before ataxia onset in autosomal dominant spinocerebellar ataxias (SCA), particularly in nucleotide repeat expansion SCAs (NRE-SCAs). However, the nature and extent of these early cognitive changes and cognition disorders remain unclear.
Objective: This scoping review maps existing evidence on cognitive alterations in pre-ataxic NRE-SCAs, focusing on affected cognitive domains, assessment tools, and early biomarkers.
Clin Neurophysiol
June 2025
Department of Neurology, Auckland City Hospital | Te Toka Tumai, Health New Zealand | Te Whatu Ora, Auckland, New Zealand; Neurogenetics Clinic, Centre for Brain Research, University of Auckland | Waipapa Taumata Rau, Auckland, New Zealand.
Objective: To estimate and compare the prevalence of sensory neuronopathy and neuropathy in autosomal dominant spinocerebellar ataxia (SCA) using neuromuscular ultrasound (NMUS) and traditional electrodiagnostic tests (EDX).
Methods: We compared NMUS [median and ulnar nerve cross-sectional areas (CSAs)] with EDX [sensory (sural, radial, median, ulnar); motor (median, ulnar, tibial)] findings from previously published and newly recruited patients with SCA (44 in total; SCA1 = 8, SCA2 = 27, SCA3 = 2; SCA6 = 7). Sensory neuronopathy was diagnosed by reduced nerve CSA on NMUS and non length-dependent sensory axonal pattern on EDX, and neuropathy by enlarged nerve CSA on NMUS and length-dependent axonal pattern on EDX.